Selectis Health, Inc. (GBCS) — SEC Filings
Selectis Health, Inc. (GBCS) — 26 SEC filings. Latest: 8-K (Dec 30, 2025). Includes 17 8-K, 6 10-Q, 2 10-K.
View Selectis Health, Inc. on SEC EDGAR
Overview
Selectis Health, Inc. (GBCS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 30, 2025: On December 30, 2025, Selectis Health, Inc. filed an 8-K report detailing a direct financial obligation and material modifications to security holder rights. The company, formerly known as Global Healthcare REIT, Inc., is incorporated in Utah and has its principal executive offices in Greenwood Vill
Sentiment Summary
Across 26 filings, the sentiment breakdown is: 1 bearish, 24 neutral, 1 mixed. The dominant filing sentiment for Selectis Health, Inc. is neutral.
Filing Type Overview
Selectis Health, Inc. (GBCS) has filed 17 8-K, 6 10-Q, 2 10-K, 1 10-K/A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (26)
Risk Profile
Risk Assessment: Of GBCS's 25 recent filings, 2 were flagged as high-risk, 14 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $10,839,954 |
| Net Income | $752,365 |
| EPS | $0.24 |
| Debt-to-Equity | N/A |
| Cash Position | $417,125 |
| Operating Margin | N/A |
| Total Assets | $33,264,355 |
| Total Debt | $38,916,242 |
Key Executives
- Chief Executive Officer
- Michael J. O'Donnell
- David J. Scholl
- David L. Johnson
- Michael J. Gontarski
Industry Context
The healthcare sector, particularly senior living and related services, is characterized by increasing demand due to an aging population. However, it is also subject to stringent regulatory oversight, labor cost pressures, and reimbursement rate fluctuations. Companies in this space often face challenges related to occupancy management and operational efficiency.
Top Tags
REIT (5) · 10-Q (4) · financials (4) · 8-k (3) · corporate-governance (3) · real-estate (3) · material-agreement (2) · Assisted Living (2) · Skilled Nursing (2) · Going Concern (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net income | $752,365 | For the three months ended September 30, 2025, a significant improvement from a $1,607,122 net loss in Q3 2024. |
| Net loss | $211,631 | For the nine months ended September 30, 2025, a reduction from $1,847,498 net loss in the prior year. |
| Healthcare Revenue | $10,839,954 | For the three months ended September 30, 2025, up from $10,016,416 in Q3 2024. |
| Income from employee retention credits | $986,423 | Recognized for the nine months ended September 30, 2025, significantly offsetting operating losses. |
| Negative net working capital | $16.3 million | As of September 30, 2025, indicating liquidity challenges. |
| Common Shares Outstanding | 3,067,059 | As of November 12, 2025, and consistent across reporting periods. |
| Basic and diluted EPS | $0.24 | For the three months ended September 30, 2025, a positive shift from $(0.52) in Q3 2024. |
| Net Loss | $963,996 | Increased from $240,376 in the prior year for the six months ended June 30, 2025, indicating worsening profitability. |
| Negative Net Working Capital | $17.2 million | As of June 30, 2025, highlighting severe liquidity issues and contributing to going concern doubt. |
| Total Expenses | $21,800,218 | Increased for the six months ended June 30, 2025, outpacing revenue growth and contributing to net loss. |
| Accumulated Deficit | $21,178,132 | As of June 30, 2025, indicating a significant historical loss position and eroding shareholder equity. |
| Cash and Cash Equivalents | $559,983 | Decreased from $680,332 at December 31, 2024, reflecting declining cash reserves. |
| Net Loss (Q2 2025) | $308,027 | A reversal from a net income of $794,344 in Q2 2024, showing a sharp decline in quarterly performance. |
| Fiscal Year End | 2024-12-31 | Reporting period for the 10-K |
| Filing Date | 2025-04-15 | Date the 10-K was submitted to the SEC |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Selectis Health, Inc. (GBCS)?
Selectis Health, Inc. has 26 recent SEC filings from Feb 2024 to Dec 2025, including 17 8-K, 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of GBCS filings?
Across 26 filings, the sentiment breakdown is: 1 bearish, 24 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Selectis Health, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Selectis Health, Inc. (GBCS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Selectis Health, Inc.?
Key financial highlights from Selectis Health, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for GBCS?
The investment thesis for GBCS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Selectis Health, Inc.?
Key executives identified across Selectis Health, Inc.'s filings include Chief Executive Officer, Michael J. O'Donnell, David J. Scholl, David L. Johnson, Michael J. Gontarski.
What are the main risk factors for Selectis Health, Inc. stock?
Of GBCS's 25 assessed filings, 2 were flagged high-risk, 14 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Selectis Health, Inc.?
Forward guidance and predictions for Selectis Health, Inc. are extracted from SEC filings as they are enriched.